FOLH1 and posterior cortical atrophy: Approved treatments for BM such as chemotherapy, highly directed external beam radiotherapy bone-modifying agents, and prostate-specific membrane antigen-targeted therapies depend on proper BM diagnosis and avoiding unnecessary treatment for bone lesions mimicking PCa BM.